Gastric cancer
Gastric cancer is one of the most common malignant tumors in my country. Its incidence rate ranks first among digestive tract tumors in my country. About 170,000 people die from gastric cancer every year. It is a disease that seriously threatens people's health. Gastric cancer can occur at any age, but it is more common in people aged 40 to 60. Males are more likely to be diagnosed than females, with a ratio of about 3:1. Cancer can occur in any part of the stomach, but it is more common in the gastric antrum, especially the lesser curvature of the stomach. The average life expectancy of untreated patients is about 13 months.
-
Site of disease:
Stomach -
Infectious :
Not contagious -
Frequent population:
50-80 years old, male to female ratio is 2 to 1, farmers... -
Related symptoms:
Stomach ache progressive weight loss upper abdominal discomfort stomach fullness vomiting blood -
Concurrent disease:
Related Drugs
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Fresenius Kabi (Wuhan) Pharmaceutical Co., Ltd.
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Hainan Huluwa Pharmaceutical Group Co., Ltd.
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Bei Jing Scrianen Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Harbin Medisan Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
GuangXi HeFeng Pharmaceutical Limited Liability Company
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Hainan Weikang Pharmaceutical(Qianshan) Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Harbin Medical University Pharmaceutical Co., Ltd.
Related Ingredients